December 29, 2025

Regencell Bioscience Holdings (RGC) Stock Analysis: Evaluating the $10.46 Billion TCM Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is carving out a niche in the healthcare sector with its focus on Traditional Chinese Medicine (TCM) aimed at treating neurocognitive disorders. Operating out..

HCA Healthcare, Inc. (HCA): Investor Outlook with Strong Revenue Growth and Analyst Consensus

HCA Healthcare, Inc. (NYSE: HCA) is a prominent name in the healthcare sector, operating an extensive network of medical care facilities across the United States. With a robust market capitalization..

Amgen Inc. (AMGN) Investor Outlook: Strong Revenue Growth and Robust Dividend Yield Highlight Investment Appeal

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture investor attention with its impressive revenue growth and robust dividend yield. As a leading player in the..

Medpace Holdings, Inc. (MEDP) Stock Analysis: A Close Look at Revenue Growth and Return on Equity

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a formidable player within the healthcare sector, specializing in diagnostics and research. With a market capitalization of $15.99 billion, Medpace offers an extensive..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 17.78% Upside Potential in the Biotechnology Sector

Roivant Sciences Ltd. (NASDAQ: ROIV) stands out in the competitive biotechnology landscape with a compelling 17.78% potential upside, according to analyst ratings. This London-based clinical-stage biopharmaceutical company is making significant..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a Potential 13.53% Upside for Investors

Align Technology, Inc. (NASDAQ: ALGN) is a significant player in the healthcare sector, specializing in medical instruments and supplies. Best known for its Invisalign clear aligners, the company is a..

Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Leader with Robust Growth Potential

Guardant Health, Inc. (NASDAQ: GH), a beacon of innovation in the healthcare sector, specifically in diagnostics and research, is capturing investor attention with its strong revenue growth and potential upside...

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a 21.98% Potential Upside Amid Healthcare Innovations

Grifols, S.A. (GRFS), a prominent player within the healthcare sector, stands as a key figure in the global plasma therapeutic space. With its headquarters nestled in Barcelona, Spain, Grifols operates..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a 19.43% Potential Upside in the Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector with its promising portfolio of treatments targeting central nervous system (CNS) disorders. Headquartered in New York, this biopharmaceutical..

Waystar Holding Corp. (WAY) Stock Analysis: A Promising 46.6% Upside in Healthcare Tech

Waystar Holding Corp. (WAY), a burgeoning entity in the healthcare sector, is drawing significant attention from investors with its innovative cloud-based software solutions for healthcare payments. Founded in 2017 and..

Johnson & Johnson (JNJ) Stock Analysis: Navigating Healthcare Growth with a $500 Billion Market Cap

Johnson & Johnson (NYSE: JNJ) stands as a titan in the healthcare industry, commanding a market capitalization of $500.24 billion. As a stalwart in the Drug Manufacturers – General industry,..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A 10% Upside Potential in the Biotech Sector

Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents an intriguing proposition for investors seeking growth within the biotechnology sector. With a market capitalization of $8.1 billion, this San Diego-based biopharmaceutical company is..

The Cigna Group (CI) Stock Analysis: A 17.51% Upside Potential Amidst Strong Analyst Support

Investors eyeing the healthcare sector should turn their attention to The Cigna Group (NYSE: CI), a stalwart in the healthcare plans industry with a market capitalization of $73.86 billion. With..

West Pharmaceutical Services (WST) Stock Analysis: A Strong Buy with 26% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a titan in the healthcare sector, particularly within the medical instruments and supplies industry, presents an alluring opportunity for investors seeking robust growth potential...

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Riding a 7.66% Potential Upside Wave in Healthcare

GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a formidable player in the healthcare sector, specializing in health information services. With a substantial market cap of $38.17 billion, the company..

Corcept Therapeutics (CORT) Stock Analysis: A Biotech Powerhouse with 53.90% Potential Upside

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology sector, has been making waves in the healthcare industry with its innovative approach to tackling severe endocrinologic, oncologic, metabolic, and..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Promising 18.55% Potential Upside for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI) stands out within the healthcare sector as a compelling investment opportunity, particularly for those focused on the dynamic medical instruments and supplies industry. With..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring Growth Potential and Market Position

Henry Schein, Inc. (HSIC) stands as a significant player in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of $9.23 billion, the company has..

Stevanato Group S.p.A. (STVN): Analyst Consensus Projects a 38% Upside for This Italian Healthcare Giant

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, has caught the attention of investors with its robust position in the medical instruments and supplies industry. Headquartered..

Tempus AI, Inc. (TEM) Stock Analysis: 41.81% Potential Upside Amid Robust Revenue Growth

Investors are keeping a close eye on Tempus AI, Inc. (NASDAQ: TEM), a healthcare technology company specializing in molecular and anatomical diagnostics, as it presents an intriguing investment opportunity with..

Search

Funds

December 29, 2025

Search

Funds

December 29, 2025

FTSE 100

Funds